Artificial Intelligence | News | Insights | AiThority
[bsfp-cryptocurrency style=”widget-18″ align=”marquee” columns=”6″ coins=”selected” coins-count=”6″ coins-selected=”BTC,ETH,XRP,LTC,EOS,ADA,XLM,NEO,LTC,EOS,XEM,DASH,USDT,BNB,QTUM,XVG,ONT,ZEC,STEEM” currency=”USD” title=”Cryptocurrency Widget” show_title=”0″ icon=”” scheme=”light” bs-show-desktop=”1″ bs-show-tablet=”1″ bs-show-phone=”1″ custom-css-class=”” custom-id=”” css=”.vc_custom_1523079266073{margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]

Current Health Enhances Oncology Patient Care

Implementation of Current Health remote patient monitoring platform at Mount Sinai aims to reduce hospital admissions and improve patient outcomes

Current Health announced that its remote patient monitoring (RPM) platform will be implemented in the Mount Sinai Health System to help manage care for cancer patients for the first time.

“Mount Sinai has always prided itself in delivering the best possible patient experiences and outcomes”

The Current Health platform monitors patients continuously and remotely, allowing physicians and nurses to provide enhanced virtual care for high-risk patients from the comfort of their home. As a result, health systems can reduce hospitalizations, expand their ability to provide care regardless of setting and – most importantly – improve patient outcomes.

Recommended AI News: Accenture Helps Rakuten Mobile Launch Fully Virtualized Cloud-Native Mobile Network

Cancer patients who are treated with chemotherapy are at increased risk for infection due to neutropenia, a decrease in white blood cells common after receiving chemotherapy. For immunocompromised cancer patients, this infection can lead to sepsis, the body’s extreme response to an infection, which can be life-threatening. To combat the risk of infection, the safest environment for patients undergoing chemotherapy is their own homes.

To enable at-home recovery for oncology patients, Mount Sinai has implemented Current Health’s RPM platform. Mount Sinai oncologists will distribute Current Health’s proprietary wearable device to high-risk cancer patients – i.e., those who are starting on a new chemotherapy regimen or those who have recently visited an oncology urgent care facility. The device continuously and passively collects vital sign data, which is then transmitted back to Mount Sinai care teams in real time. The platform alerts physicians to data abnormalities and potential issues, allowing them to proactively intervene as needed, rather than relying on patients to determine when they may or may not need medical assistance. By managing patient care remotely, Mount Sinai aims to reduce hospitalization events, prevent potential patient exposure to infection, and bridge the digital health divide as more and more patients have engaged in telehealth. This ability to treat patients outside the hospital is especially critical given the delay in care for many cancer patients due to concerns around COVID-19.

Recommended AI News: Twitter Selects AWS as Strategic Provider to Serve Timelines

Christopher McCann, CEO and Co-Founder of Current Health, added, “More and more, we’re seeing patient demand for more home-based care options. Mount Sinai is at the forefront of this trend, enabling oncology patients to recover at home under the watchful eye of their physicians. Their commitment to delivering best-in-class patient experiences and outcomes is a true model for forward-thinking providers.”

“Mount Sinai has always prided itself in delivering the best possible patient experiences and outcomes,” said Dr. Cardinale Smith, Chief Quality Officer for Cancer Services for the Mount Sinai Health System, who is leading the remote monitoring program of cancer patients at Mount Sinai. “It’s important to us that our patients know they are being monitored by qualified care teams and supported during an exceptionally uncertain and stressful time. The Mount Sinai Health System has been one of the earliest adopters of home-based care models and one of the first to prove that it works. With technological advancements like Current Health’s RPM platform, we can expand the health system’s capabilities to do this for high-risk cancer patients.”

Recommended AI News: Star Alliance Expands Strategic Partnership with TCS to Deliver Enhanced Customer Experiences

Related Posts
1 of 15,715

Leave A Reply

Your email address will not be published.